Collegium Pharmaceutical, Inc. COLL Income Tax
Income Tax at other companies
Segments
By segment
Other financials
Where this comes from
Reported directly by Collegium Pharmaceutical, Inc. in its filing.
Tagged under the XBRL concept us-gaap:IncomeTaxExpenseBenefit.
The official record: Collegium Pharmaceutical, Inc.’s 10-Q, filed May 7, 2026, on SEC EDGAR. View the filing →
Ask your AI about Collegium Pharmaceutical, Inc.'s income tax.
Connect your AI assistant and compare it to peers, right in your chat.
Connect your AI
Claude
Questions, answered.
- What is Collegium Pharmaceutical, Inc.'s income tax?
- Collegium Pharmaceutical, Inc. (COLL) reported income tax of $4.24M in Q1 2026.
- How has Collegium Pharmaceutical, Inc.'s income tax changed year-over-year?
- Collegium Pharmaceutical, Inc.'s income tax increased by 502.0% year-over-year, from $705K to $4.24M.
- What is the long-term trend for Collegium Pharmaceutical, Inc.'s income tax?
- Over 4 years (2021 to 2025), Collegium Pharmaceutical, Inc.'s income tax has grown at a -20.6% compound annual growth rate (CAGR), from -$74.89M to $29.75M.
- What does income tax mean?
- Total income tax expense (current + deferred) recognized in the income statement, representing the company's total tax obligation on pre-tax income.